Mendota Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.9K Hold
20
0.01% 79
2025
Q1
$9.7K Hold
20
0.01% 80
2024
Q4
$8.05K Sell
20
-21
-51% -$8.46K 0.01% 247
2024
Q3
$19.1K Sell
41
-39
-49% -$18.1K 0.01% 215
2024
Q2
$37.5K Hold
80
0.02% 189
2024
Q1
$33.4K Sell
80
-41
-34% -$17.1K 0.02% 193
2023
Q4
$49.2K Buy
+121
New +$49.2K 0.04% 202